SI c.214A>G ;(p.N72D)

Variant ID: 3-164792360-T-C

NM_001041.3(SI):c.214A>G;(p.N72D)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?

Journal For Immunotherapy Of Cancer
Ménétrier-Caux, Christine C; Ray-Coquard, Isabelle I; Blay, Jean-Yves JY; Caux, Christophe C
Publication Date: 2019-03-28

Variant appearance in text: SI: N72D
PubMed Link: 30922400
Variant Present in the following documents:
  • 40425_2019_Article_549.pdf
View BVdb publication page



IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Zhang, Meili M; Wen, Bernard B; Anton, Olga M OM; Yao, Zhengsheng Z; Dubois, Sigrid S; Ju, Wei W; Sato, Noriko N; DiLillo, David J DJ; Bamford, Richard N RN; Ravetch, Jeffrey V JV; Waldmann, Thomas A TA
Publication Date: 2018-11-13

Variant appearance in text: SI: N72D
PubMed Link: 30373815
Variant Present in the following documents:
  • Main text
View BVdb publication page



Cooperative therapeutic anti-tumor effect of IL-15 agonist ALT-803 and co-targeting soluble NKG2D ligand sMIC.

Oncotarget
Basher, Fahmin F; Jeng, Emily K EK; Wong, Hing H; Wu, Jennifer J
Publication Date: 2016-01-05

Variant appearance in text: SI: N72D
PubMed Link: 26625316
Variant Present in the following documents:
  • oncotarget-07-0814.pdf
View BVdb publication page